Skip to content

Insider · CIK 0001779581

Dario Scimeca

officer

Files at DTIL (PRECISION BIOSCIENCES INC). First filing Nov 6, 2023, latest Feb 19, 2026.

In brief

Dario Scimeca files SEC Form 4 as officer at DTIL (PRECISION BIOSCIENCES INC). Since Nov 6, 2023, Dario Scimeca has reported 0 open-market buys worth $0 and 5 open-market sells worth $70k, the latest filed on Feb 19, 2026.

A track record needs three past buys with six months of prices behind them; Dario Scimeca has 0, so none is measured yet.

The newest scored trade: sold $19k of DTIL on Feb 18, 2026, filed Feb 19, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $59k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $70k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

DTIL: PRECISION BIOSCIENCES INC

DTILOct 9, 2026 · close 6.72

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
DTILsell 410b5-1
PRECISION BIOSCIENCES INC
$19k
4,925 shares
-8%+8% from low-55% from high
6Weak
DTILsell 410b5-1
PRECISION BIOSCIENCES INC
$36k
8,854 shares
-17%+3% from low-53% from high
0Weak
DTILsell 310b5-1
PRECISION BIOSCIENCES INC
$4,316
665 shares
-2%+93% from low-15% from high
0Weak
DTILsell 210b5-1
PRECISION BIOSCIENCES INC
$4,816
588 shares
-7%-
0Weak
DTILsell 210b5-1
PRECISION BIOSCIENCES INC
$6,409
16,023 shares
-12%+49% from low-73% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Feb 18, 2026 DTIL
PRECISION BIOSCIENCES INC
4,925
0.04% of outstanding
$19kFeb 18, 2026$36k
Jan 21, 2026 DTIL
PRECISION BIOSCIENCES INC
8,854
0.07% of outstanding
$36kJan 21, 2026$4,315
Nov 3, 2025 DTIL
PRECISION BIOSCIENCES INC
665
0.01% of outstanding
$4,315Nov 3, 2025none
Mar 4, 2025 DTIL
PRECISION BIOSCIENCES INC
272
0.00% of outstanding
$1,336Mar 4, 2025$43k
Jan 22, 2025 DTIL
PRECISION BIOSCIENCES INC
8,928
0.12% of outstanding
$43kJan 22, 2025$4,816
Nov 4, 2024 DTIL
PRECISION BIOSCIENCES INC
588
0.01% of outstanding
$4,816Nov 4, 2024none
Jan 22, 2024 DTIL
PRECISION BIOSCIENCES INC
21,287
0.02% of outstanding
$7,755Jan 22, 2024$6,417
Nov 3, 2023 DTIL
PRECISION BIOSCIENCES INC
16,023
0.01% of outstanding
$6,417Nov 3, 2023none

Transactions

Every row this insider has filed, 21 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 1, 2026DTIL
PRECISION BIOSCIENCES INC
AGrant or award
Restricted Stock Unitsderivative
+107,604$0.00$0107,604Jun 3, 2026
Feb 17, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+16,667$0.00$061,382Feb 19, 2026
Feb 18, 2026DTIL
PRECISION BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-4,925$3.84$19k56,457Feb 19, 2026
Feb 17, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-16,667$0.00$033,333Feb 19, 2026
Jan 20, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,978$0.00$030,236Jan 22, 2026
Jan 20, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+8,425$0.00$038,661Jan 22, 2026
Jan 20, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+14,908$0.00$053,569Jan 22, 2026
Jan 21, 2026DTIL
PRECISION BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-8,854$4.03$36k44,715Jan 22, 2026
Jan 20, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-1,978$0.00$00Jan 22, 2026
Jan 20, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-8,425$0.00$08,425Jan 22, 2026
Jan 20, 2026DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-14,908$0.00$014,907Jan 22, 2026
Nov 2, 2025DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,835$0.00$028,923Nov 4, 2025
Nov 3, 2025DTIL
PRECISION BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-665$6.49$4,31628,258Nov 4, 2025
Nov 2, 2025DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-1,835$0.00$00Nov 4, 2025
Jun 2, 2025DTIL
PRECISION BIOSCIENCES INC
AGrant or award
Restricted Stock Unitsderivative
+50,000$0.00$050,000Jun 4, 2025
Nov 2, 2024DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+1,836$0.00$08,557Nov 5, 2024
Nov 4, 2024DTIL
PRECISION BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-588$8.19$4,8167,969Nov 5, 2024
Nov 2, 2024DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-1,836$0.00$01,835Nov 5, 2024
Nov 2, 2023DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Common Stock10b5-1
+55,077--128,993Nov 6, 2023
Nov 3, 2023DTIL
PRECISION BIOSCIENCES INC
SOpen-market sale
Common Stock10b5-1
-16,023$0.40$6,409112,970Nov 6, 2023
Nov 2, 2023DTIL
PRECISION BIOSCIENCES INC
MOption exercise
Restricted Stock Unitsderivative10b5-1
-55,077$0.00$0110,123Nov 6, 2023

Questions about Dario Scimeca

Answered from the filings on this page, as of the latest one.

Is Dario Scimeca buying or selling?

In the last 12 months Dario Scimeca reported 0 open-market buys worth $0 and 3 open-market sells worth $59k on SEC Form 4; the latest was sold $19k of DTIL on Feb 18, 2026. Grants, option exercises and tax withholding are not counted.

How did Dario Scimeca's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dario Scimeca has 0.

Where does Dario Scimeca file Form 4?

Dario Scimeca has filed Form 4 at DTIL (PRECISION BIOSCIENCES INC) as General Counsel and Secretary. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.